Press release
Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033
Fecal Microbiota Transplantation (FMT) Market Key Drivers
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp
According to The Business Research Company's, The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.80 billion in 2023 to $0.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growing awareness of gut microbiome, expanding therapeutic applications, increasing personalized medicine, adoption in gastroenterology practices, increasing number of clinical trials and increasing funding and investments.
The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing incidence of clostridium difficile infections (CDI), rising prevalence of inflammatory bowel diseases, increasing research and development activities, rising geriatric population, and expanding healthcare infrastructure. Major trends in the forecast period include the development of standardized protocols for donor screening, stool preparation, advances in microbiome analysis, improved stool processing technologies, novel delivery methods, and the development of synthetic or standardized microbiota-based products.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/fecal-microbiota-transplantation-fmt-global-market-report
Market Drivers and Trends:
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the fecal microbiota transplantation (FMT) market going forward. Gastrointestinal (GI) disorders refer to a wide range of conditions that affect the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and anus. The rise in gastrointestinal disorders is due to increased stress, sedentary lifestyles, and higher consumption of processed foods. Fecal microbiota transplantation is used in gastrointestinal disorders to restore healthy gut bacteria, particularly for treating recurrent Clostridioides difficile infections. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the rising prevalence of gastrointestinal disorders drives the growth of the fecal microbiota transplantation (FMT) market.
Major companies operating in the fecal microbiota transplantation (FMT) market are focusing on developing innovative solutions, such as microbiota-based live biotherapeutics, to enhance treatment efficacy for gastrointestinal disorders. Microbiota-based live biotherapeutics refer to live microorganisms used as therapeutic agents to restore or modify the gut microbiome for treating various diseases. For instance, in November 2022, Ferring Pharmaceuticals, a Switzerland-based biopharmaceutical company, received US Food and Drug Administration (FDA) approval for REBYOTA (fecal microbiota, live-jslm), a novel first-in-class microbiota-based live biotherapeutic indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment for recurrent CDI. REBYOTA is indicated for preventing Clostridioides difficile (C. difficile) infection recurrence in individuals 18 years of age and older following antibiotic treatment for recurrent CDI.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc., Finch Therapeutics Group Inc., Locus Biosciences, Yeda Research and Development Co. Ltd., Microbiotica Limited, CosmosID Inc., AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope
Fecal Microbiota Transplantation (FMT) Market 2024 Key Insights:
• The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.
• Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market
• Innovative Advancements In Fecal Microbiota Transplantation Enhanced Market Growth
• North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=19430&type=smp
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033 here
News-ID: 3760635 • Views: …
More Releases from The Business research company
Zymfentra Market Report Examines Leading Companies And Growth Opportunities
Understanding the Future Outlook of the Zymfentra Market
The Zymfentra market has been evolving steadily, driven by scientific advances and growing healthcare infrastructure. Looking ahead to 2030, the market is expected to witness considerable growth fueled by multiple factors influencing both development and patient care.
Market Size and Growth Drivers for the Zymfentra Market
During the historical period, growth was primarily propelled by improvements in recombinant enzyme technology and better diagnostic…
Zenpep Market Report Provides Insights Into Market Evolution And Growth Prospect …
The Zenpep market is gaining momentum as advancements in digestive health treatments and better disease management continue to evolve. With rising awareness and improved therapies, this sector is positioned for steady growth in the coming years. Let's explore the current market value, key factors driving expansion, leading players, and important segments shaping the future of Zenpep.
Projected Market Value and Growth Drivers for Zenpep by 2030
Historical growth in the Zenpep…
Xyntha,Xyntha Solofuse Market Report Examines Leading Companies And Growth Oppor …
The market for Xyntha and Xyntha Solofuse is poised for significant growth as advancements in hemophilia A treatment continue to evolve. With shifts toward more effective therapies and improved patient management strategies, this industry is set to witness substantial expansion in the coming years. Let's explore the current market value, the key factors driving growth, prominent players, and the main market segments shaping the landscape.
Expected Market Value of the Xyntha…
Xembify Market Report Provides Insights Into Market Evolution And Growth Prospec …
The Xembify market is gaining considerable attention due to advances in treatment options and increased awareness of immune-related disorders. This sector is evolving rapidly, driven by improvements in therapies and expanding patient access. Let's explore the current market size, key growth drivers, prominent players, and emerging trends shaping the future of Xembify.
Market Growth and Prospects for the Xembify Market
The historical expansion of the Xembify market is largely linked to…
More Releases for FMT
Fecal Microbiota Transplantation (FMT) Market Research Reveals Path To $1.27 Bil …
The fecal microbiota transplantation (FMT) market is positioned for significant advancement as growing scientific interest and technological improvements fuel its expansion. With increasing applications beyond traditional gastrointestinal treatments and ongoing innovations in delivery and manufacturing, this sector is on track for meaningful growth in the coming years. Below is an overview of the market's size, leading companies, emerging trends, and segment details.
Projected Market Size and Growth Outlook of the Fecal…
Fecal Microbiota Transplantation (FMT) Market Overview, Key Trends, and Major Pl …
The fecal microbiota transplantation (FMT) market is gaining significant traction as research around microbiome-based therapies advances and new applications emerge. With growing demand for standardized treatments and innovative delivery methods, this sector is set to experience substantial growth over the coming years. Here's a detailed overview of the market's valuation, key players, emerging trends, and segmentation.
Projected Market Value and Growth Outlook for Fecal Microbiota Transplantation (FMT)
The FMT market is…
Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Trans …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Fecal Microbiota Transplantation (FMT) Market Size By 2025?
In recent times, there has been a substantial expansion in the size of the fecal microbiota transplantation (FMT) market. The market value is predicted to rise from $0.85 billion in 2024 to $0.91 billion in 2025, with…
Global and United States Fecal Microbiota Transplantation (FMT) Market to Witnes …
The Fecal Microbiota Transplantation(FMT) research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant market key players are also enlisted in order to deliver readers with in-depth analysis about industry strategies.
The…
Aerobridge Market by Manufacturers: ADELTE, FMT, HÜBNER, JBT AeroTech, thyssenk …
Aerobridge Market research report aids accomplish the needs of businesses for which it analyses the market from top to bottom by considering plentiful parameters. A strong research methodology used here consists of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. The Aerobridge Market report first…
Aerobridge Market to Witness Huge Growth by 2026 | ADELTE, FMT, HÜBNER, AeroTech
Global (United States, European Union and China) Aerobridge Market Research Report 2019-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global (United States, European Union and China) Aerobridge Market. Some of the key players…
